Fresenius Kidney Centers, officially operating under the brand name Fresenius Kidney Care, are owned and operated by Fresenius Medical Care North America, which is the North American operating division of Fresenius Medical Care AG. Fresenius Medical Care is a publicly traded international healthcare enterprise listed on major stock exchanges including the Frankfurt Stock Exchange and the New York Stock Exchange under the ticker symbol FMS. The largest shareholder and strategic anchor investor in Fresenius Medical Care is the parent German healthcare conglomerate Fresenius SE & Co. KGaA, which holds a thirty-two percent ownership stake alongside voting rights. The remaining shares of Fresenius Medical Care are owned by a broad spectrum of global institutional investors, mutual funds, and individual public shareholders, establishing a corporate structure that combines public market backing with deep healthcare group heritage.